A detailed history of Vest Gen Advisors, LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Vest Gen Advisors, LLC holds 12,238 shares of LLY stock, worth $12.5 Million. This represents 0.31% of its overall portfolio holdings.

Number of Shares
12,238
Previous 17,270 29.14%
Holding current value
$12.5 Million
Previous $13.5 Billion 30.59%
% of portfolio
0.31%
Previous 0.54%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 14, 2025

SELL
$625.65 - $812.69 $3.15 Million - $4.09 Million
-5,032 Reduced 29.14%
12,238 $9.34 Billion
Q2 2025

Aug 13, 2025

BUY
$713.71 - $898.95 $2.2 Million - $2.77 Million
3,084 Added 21.74%
17,270 $13.5 Billion
Q1 2025

May 13, 2025

BUY
$725.72 - $929.72 $10.3 Million - $13.2 Million
14,186 New
14,186 $11.7 Billion

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $971B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Vest Gen Advisors, LLC Portfolio

Follow Vest Gen Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Vest Gen Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Vest Gen Advisors, LLC with notifications on news.